Metabolic brain diseaseGastrointestinal MicrobiomeHumansParkinson Diseasealpha-Synucleinbeta-Glucans
Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson's disease.
Faezeh Hatami, Zahra Aghelan, Mahan Rezaie Pouya, Melina Moulaeian, Ali Rastegari, Seyed Hosien Abtahi, Shaghayegh Hoseini
Published: 202510.1007/s11011-025-01711-w
Abstract
Parkinson's disease (PD) ranks as the second most prevalent neurodegenerative condition affecting individuals in their middle age and beyond. Its hallmark features include the abnormal accumulation of α-synuclein protein and the progressive loss of d…
Preview only. Read the full abstract at the source